News ArchivesRead News
New Drugs May Help With Parkinson’s Disease
Friday July 25, 2014
eMissourian - About 60,000 Americans are diagnosed with Parkinson’s disease each year. In 2010, the disease was responsible for the deaths of 22 Missouri residents between the ages of 65 and 74, and 169 Missouri residents over the age of 75, according to the Centers for Disease Control and Prevention.
Parkinson’s disease is a progressive disorder of the nervous system that affects your movement. It develops gradually, sometimes starting with a barely noticeable tremor in just one hand.
But while a tremor may be the most well-known sign of Parkinson’s disease, there are several other symptoms and signs that may vary from person to person. Early signs may be mild and go unnoticed.
Symptoms often begin on one side of your body and usually remain worse on that side, even after symptoms begin to affect both sides. Signs and symptoms may include tremor, slowed movement, rigid muscles, impaired posture, speech changes and writing changes.
In the early stages of Parkinson’s disease, your face may show little or no expression or your arms may not swing when you walk. Your speech may become soft or slurred.
Parkinson’s disease symptoms worsen as your condition progresses over time. Although Parkinson’s disease can’t be cured, medications may markedly improve your symptoms. In occasional cases, your doctor may suggest surgery to regulate certain regions of your brain and improve your symptoms.
One of the most disturbing side effects of standard Parkinson’s disease treatments are “freezing” or “off” episodes characterized by acute immobility. These episodes can occur between one and several times a day and last from one to several hours cumulatively.
These episodes are triggered by L-dopa, a mainline treatment for Parkinson’s disease. The episodes begin when the levodopa or enzyme inhibitors enter the bloodstream too slowly, or wear off quickly, or just do not enter the bloodstream sufficiently at all.
A drug called apomorphine is the only drug approved specifically for the treatment of these “freezing” periods. Currently, however, it is only available in the United States as an injection. This can result in painful reactions, including irritation and nodules at the injection site.
As an alternative, Cynapsus Therapeutics Inc. has developed an under-the-tongue thin-film strip system, called APL-130277 that is similar to Listerine Breath Strips. The strip dissolves in about one to two minutes, delivering the drug into the bloodstream in a similar time interval and concentration as an injectable dose.
The treatment aims at relieving many Parkinson’s disease patients of the requirement for self-injections, along with the injury and stress this entails.
Over the next two years, the company plans to conduct human clinical trials and expects to submit its drug for approval to the U.S. Food and Drug Administration in 2016.
If you would like to learn more about Parkinson’s disease, its symptoms and available treatments speak with your doctor or contact the Movement Disorders Center at the Washington University in St. Louis School of Medicine, 314- 362-6908 or http://neuro.wustl.edu/patientcare/clinicalservices/movementdisorders/.
Anthony Giovinazzo is president and CEO of Cynapsus Therapeutics Inc., which is developing the only noninjectable (sublingual) delivery of the only approved drug (apomorphine) to be used as a rescue therapy for “off” motor symptoms of Parkinson’s disease.
Giovinazzo, Anthony. (25 July 2014). eMissourian. New Drugs Ma. http://www.emissourian.com/new-drugs-may-help-with-parkinson-s-disease/article_4ae248fc-4c93-59cc-8367-9a115906ce21.htmly Help With Parkinson’s Disease
Recent NewsMay 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis
Apr 12 - Obstructive Sleep Apnea Affects Cognition in Parkinson's Disease
Apr 11 - Seattle boxing gym giving hope to Parkinson's patients
Apr 10 - A new rhythm
Apr 10 - Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy
Apr 6 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Apr 5 - Combatting the isolation of young onset Parkinson's disease
Apr 1 - The Kid is Alright